These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28275089)

  • 1. The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.
    Vetter NS; Kolb EA; Mills CC; Sampson VB
    Mol Cancer Res; 2017 Jul; 15(7):953-964. PubMed ID: 28275089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
    Chakravarthi BVSK; Chandrashekar DS; Agarwal S; Balasubramanya SAH; Pathi SS; Goswami MT; Jing X; Wang R; Mehra R; Asangani IA; Chinnaiyan AM; Manne U; Sonpavde G; Netto GJ; Gordetsky J; Varambally S
    Mol Cancer Res; 2018 Jul; 16(7):1125-1137. PubMed ID: 29025958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JMJD2A participates in cytoskeletal remodeling to regulate castration-resistant prostate cancer docetaxel resistance.
    Cai X; Duan X; Tang T; Cui S; Wu T
    BMC Cancer; 2023 May; 23(1):423. PubMed ID: 37165308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stathmin 1 is a potential novel oncogene in melanoma.
    Chen J; Abi-Daoud M; Wang A; Yang X; Zhang X; Feilotter HE; Tron VA
    Oncogene; 2013 Mar; 32(10):1330-7. PubMed ID: 22665054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-34a inhibits tumor invasion and metastasis in osteosarcoma partly by effecting C-IAP2 and Bcl-2.
    Wen J; Zhao YK; Liu Y; Zhao JF
    Tumour Biol; 2017 Jun; 39(6):1010428317705761. PubMed ID: 28635396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1.
    Wang X; Peng L; Gong X; Zhang X; Sun R; Du J
    Cell Physiol Biochem; 2018; 50(6):2249-2259. PubMed ID: 30423576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene.
    Pu Y; Zhao F; Li Y; Cui M; Wang H; Meng X; Cai S
    BMC Cancer; 2017 Jan; 17(1):45. PubMed ID: 28073349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma.
    Sampson VB; Vetter NS; Zhang W; Patil PU; Mason RW; George E; Gorlick R; Kolb EA
    Oncotarget; 2016 Dec; 7(52):86594-86607. PubMed ID: 27863409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal.
    Li QC; Xu H; Wang X; Wang T; Wu J
    Cancer Biomark; 2017 Dec; 21(1):135-144. PubMed ID: 29060932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1.
    Zhu L; Chen Y; Nie K; Xiao Y; Yu H
    Cancer Biomark; 2018; 23(2):301-309. PubMed ID: 30198871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
    Wang S; Akhtar J; Wang Z
    Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-490-3p regulates cell proliferation and apoptosis by targeting HMGA2 in osteosarcoma.
    Liu W; Xu G; Liu H; Li T
    FEBS Lett; 2015 Oct; 589(20 Pt B):3148-53. PubMed ID: 26341146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion.
    Bayraktar R; Ivan C; Bayraktar E; Kanlikilicer P; Kabil NN; Kahraman N; Mokhlis HA; Karakas D; Rodriguez-Aguayo C; Arslan A; Sheng J; Wong S; Lopez-Berestein G; Calin GA; Ozpolat B
    Clin Cancer Res; 2018 Sep; 24(17):4225-4241. PubMed ID: 29748184
    [No Abstract]   [Full Text] [Related]  

  • 15. Loss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma.
    Birnie KA; Yip YY; Ng DC; Kirschner MB; Reid G; Prêle CM; Musk AW; Lee YC; Thompson PJ; Mutsaers SE; Badrian B
    Mol Cancer Res; 2015 Jul; 13(7):1106-18. PubMed ID: 25824152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether à go-go 1 expression.
    Wu X; Zhong D; Gao Q; Zhai W; Ding Z; Wu J
    Int J Med Sci; 2013; 10(6):676-82. PubMed ID: 23569431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest.
    Zhao Y; Tu MJ; Wang WP; Qiu JX; Yu AX; Yu AM
    Sci Rep; 2016 May; 6():26611. PubMed ID: 27216562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RNA-binding protein SART3 promotes miR-34a biogenesis and G
    Sherman EJ; Mitchell DC; Garner AL
    J Biol Chem; 2019 Nov; 294(46):17188-17196. PubMed ID: 31619517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-206 Reduces Osteosarcoma Cell Malignancy
    Zhan FB; Zhang XW; Feng SL; Cheng J; Zhang Y; Li B; Xie LZ; Deng QR
    Yonsei Med J; 2019 Feb; 60(2):163-173. PubMed ID: 30666838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential combinational effect of miR-34a with celecoxib in osteosarcoma.
    Chen X; Peng D; Shen Y; Liu B; Zhou H; Tao H; Huang J
    Anticancer Drugs; 2017 Sep; 28(8):888-897. PubMed ID: 28650862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.